Using nationally representative survey data for external adjustment of unmeasured confounders: An example using the NHANES data

Use of real‐world evidence from healthcare utilization data to evaluate drug safety during pregnancy

(2019) Krista F. Huybrechts et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Association between maternal body mass index and congenital heart defects in infants: A meta-analysis

(2018) Yu Zhu et al.   Congenital Heart Disease

Increased maternal Body Mass Index is associated with congenital heart defects: An updated meta-analysis of observational studies

(2018) Zan Zheng et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Is maternal smoking during pregnancy associated with an increased risk of congenital heart defects among offspring? A systematic review and meta-analysis of observational studies

(2016) Dongyu Zhang et al.   Journal of Maternal-Fetal & Neonatal Medicine

Antidepressant Use in Pregnancy and the Risk of Cardiac Defects

(2014) Krista F. Huybrechts et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validity of maternal and infant outcomes within nationwide Medicaid data

(2014) Kristin Palmsten et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

National trends in antidepressant medication treatment among publicly insured pregnant women

(2013) Krista F. Huybrechts et al.   GENERAL HOSPITAL PSYCHIATRY

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations

(2013) Kristin Palmsten et al.   PLoS One

Maternal Smoking During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Metaanalysis

(2012) Laura J. Lee et al.   PEDIATRIC CARDIOLOGY

Bias Formulas for Sensitivity Analysis of Unmeasured Confounding for General Outcomes, Treatments, and Confounders

(2010) Tyler J. VanderWeele et al.   EPIDEMIOLOGY

Methods to apply probabilistic bias analysis to summary estimates of association

(2010) Timothy L. Lash et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY